A comparative analysis on the efficacy of sumamigren in treatment menstrual and non-menstrual migraine attacks

Tabeeva G.R.

Moskovskaia meditsinskaia akademiia im. I.M. Sechenova

Gromova S.A.

Authors:

Tabeeva G.R., Gromova S.A.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2011;111(7): 44‑48

Downloaded: 13

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Tabeeva GR, Gromova SA. A comparative analysis on the efficacy of sumamigren in treatment menstrual and non-menstrual migraine attacks. S.S. Korsakov Journal of Neurology and Psychiatry. 2011;111(7):44‑48. (In Russ.)

Close metadata

Recommended articles:

Influence of Clinical, Laboratory and Intraoperative Parameters on Postoperative Complications in Geriatric Patients with Acute Appendicitis: A Cross-Sectional Analysis. Pirogov Russian Journal of Surgery. 2024;(11):106-112

Based on the headache diaries, authors compared clinical presentations, degree of disability and efficacy of sumamigren (sumatriptan) in treatment menstrual and non-menstrual migraine attacks in 27 women (mean age 35±1.7 years). The diagnosis of menstrual-associated migraine was made in accordance with a supplement to the International Classification of Headache Disorders. 2nd edition. The clinical characteristics and degree of reduction of disability in menstrual and non-menstrual migraine attacks did not differ during the treatment. Efficacy of sumamigren was comparable in both types of attacks.

Keywords:

menstrual-associated migraine

menstrual and non-menstrual attacks

clinical characteristics

sumamigren

Authors:

Tabeeva G.R.

Moskovskaia meditsinskaia akademiia im. I.M. Sechenova

Gromova S.A.

List of references:

Tabeeva G.R., Azimova Yu.E.Effektivnost' sumamigrena pri ego naznachenii v rannem i pozdnem periodakh razvitiya migrenoznogo pristupa. Zhurn nevrol i psikhiat 2007; 107: 8: 22-26.
Tabeeva G.R., Gromova S.A.Menstrual'naya migren': epidemiologiya, patogenez, diagnostika, klinicheskie osobennosti. Nevrol, neiropsikhiat, psikhosomatika 2010; 2: 11-19.
Mezhdunarodnaya klassifikatsiya golovnoi boli. 2-e izd. Mezhdunarodnoe obshchestvo golovnoi boli 2003. Per. V.V. Osipovoi, T.G. Voznesenskoi. Gedeon Rikhter 2003.
Allais G., Acuto G., Cabarrocas X. et al.Efficacy and tolerability of almotriptan versus zolmitriptan for the acute treatment of menstrual migraine. Neurol Sci 2006; 27: Suppl 2: 193-197.
Couturier E.G.M., Bomhof M.A.M., Knuistingh Neven A., van Duijn N.P.Menstrual migraine in a representative Dutch population sample: prevalence, disability and treatment. Cephalalgia 2003; 23: 302-308.
Diamond M.L., Cady R.K., Mao L. et al.Characteristics of migraine attacks and responses to almotriptan treatment: a comparison of menstrually related and nonmenstrually related migraines. Headache 2008; 48: 2: 248-258.
Dowson A.J., Massiou H., Aurora S.K.Managing migraine headaches experienced by patients who self-report with menstrually related migraine: a prospective, placebo-controlled study with oral sumatriptan. J Headache Pain 2005; 6: 81-87.
Dowson A.J., Kilminster S.G., Salt R. et al.Disability Associated With Headaches Occurring Inside and Outside the Menstrual Period in Those With Migraine: A General Practice Study. Headache 2005; 45: 274-282.
Granella F., Sances G., Allais G.et al.Characteristics of menstrual and nonmenstrual attacks in women with menstrually related migraine referred to headache centres. Cephalalgia 2004; 24: 707-716.
Gross M.L.P., Barrie M., Bates D. et al.The efficacy of oral sumatriptan in menstrual migraine-a prospective study. Poster presented at the 7th International Headache Congress, 16-20 September, 1995; Toronto, Canada.
Headache Classification Committee of the International Society (2004) The International Classification of Headache Disorders. Cephalalgia 24: Suppl 1: 1-160.
Landy S., Savani N., Shackelford S. et al.Efficacy and tolerability of sumatriptan tablets administered during the mild-pain phase of menstrually associated migraine. Int J Clin Pract 2004; 58: 913-919.
Loder E., Silberstein S.D., Abu-Shakra S. et al.Efficacy and tolerability of oral zolmitriptan in menstrually associated migraine: A randomized prospective parallel-group double-blind placebo-controlled study. Headache 2004; 44: 120-130.
MacGregor E.A., Hackshaw A.Prevalence of migraine on each day of the natural menstrual cycle. Neurology 2004; 27: 63: 2: 351-353.
Mannix L.K., Loder E., Nett R. et al.Rizatriptan for the acute treatment of ICHD-II proposed menstrual migraine: two prospective randomized placebo-controlled double-blind studies. Cephalalgia 2007; 27: 414-421.
Martin V.T., Wernke S., Mandell K. et al.Defining the relationship between ovarian hormones and migraine headache. Headache 2005; 45: 1190-1201.
Martin V., Cady R., Mauskop A. et al.Efficacy of Rizatriptan for Menstrual Migraine in an Early Intervention Model: A Prospective Subgroup Analysis of the Rizatriptan TAME (Treat A Migraine Early) Studies Headache 2007; 48: Issue 2: 226-235.
Massioua H., Jaminb C., Hinzelinc G., Bidaut-Mazeld C.The French Naramig Collaborative Study Group Efficacy of oral naratriptan in the treatment of menstrually related migraine. Eur J Neurol 2005;12:774-781.
Mathew N.T., Finlayson G., Smith T.R. et al.Early intervention with almotriptan: Results of the AEGIS trial (AXERT Early miGraine Intervention Study). Headache 2007; 47: 189-198.
Nett R., Landy S., Shackelford S.Pain-free efficacy after treatment with sumatriptan in the mild pain phase of menstrually associated migraine. Obstet Gynecol 2003; 102: 835-842.
Nett R., Mannix L.K., Mueller L.Rizatriptan Efficacy in ICHD-II Pure Menstrual Migraine and Menstrually Related Migraine Headache 2008; 48: 8: 1194-1201.
Silberstein S.D., Massiou H., Le Jeunne C. et al.Rizatriptan in the treatment of menstrual migraine. Obstet Gynecol 2000; 96: 237-242.
Stewart W.F., Lipton R.B., Chee E. et al.Menstrual cycle and headache in a population sample of migraineurs. Neurology 2000; 28: 55: 10: 1517-1523.

Close metadata